Based on our data, attenuation of podocyte injury may be associated with reducing hyperglycemia, upregulation of SOD-1/SOD-3 mRNA expression, and downregulation of the TRPC6 mRNA expression in the CeA treatment in early hyperglycemia condition (Figures 2 and 3). The gene discussed is TRPC6; the disease is Hyperglycemia.